| Dr Anthony Louis Greco, MD | |
|
411 Laurel St Ste A120, Des Moines, IA 50314-3027 | |
| (515) 643-7900 | |
| (515) 643-7901 |
| Full Name | Dr Anthony Louis Greco |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 9 Years |
| Location | 411 Laurel St Ste A120, Des Moines, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073909545 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercyone Des Moines Medical Center | Des moines, IA | Hospital |
| Pella Regional Health Center | Pella, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Clinics Inc | 7911810882 | 373 |
News Archive
Today (Wednesday 24 June 2015) His Royal Highness The Prince Charles, Duke of Rothesay will officially open the Golden Jubilee Innovation Centre – a focal point for driving forward innovations for NHSScotland.
Each cell in an organism has a sensor that measures the health of its "internal" environment. This "alarm" is found in the endoplasmic reticulum, which is able to sense cellular stress and trigger either rescue responses or the death of the cell.
More than one-third of mothers and about one-fifth of fathers in the United Kingdom appear to experience an episode of depression between their child's birth and 12th year of age, with the highest rates in the first year after birth, according to a report posted online today that will appear in the November print issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
BioSante Pharmaceuticals, Inc., today announced additional positive safety data in its ongoing LibiGel Phase III clinical development program. For the second time, unblinded data have been reviewed by the independent DMC of the LibiGel Cardiovascular and Breast Cancer Safety Study. Based on this review, the DMC once again unanimously recommended continuation of the study as described in the FDA-agreed LibiGel safety study protocol, with no modifications.
A phase 1 clinical trial of sotorasib (AMG 510) in patients with heavily pretreated advanced solid tumors shows encouraging anti-cancer activity, especially in lung and colorectal cancers, reports a new study led by City of Hope and other renowned comprehensive cancer centers.
› Verified 3 days ago
| Entity Name | Mercy Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457691941 PECOS PAC ID: 7911810882 Enrollment ID: O20031112000238 |
News Archive
Today (Wednesday 24 June 2015) His Royal Highness The Prince Charles, Duke of Rothesay will officially open the Golden Jubilee Innovation Centre – a focal point for driving forward innovations for NHSScotland.
Each cell in an organism has a sensor that measures the health of its "internal" environment. This "alarm" is found in the endoplasmic reticulum, which is able to sense cellular stress and trigger either rescue responses or the death of the cell.
More than one-third of mothers and about one-fifth of fathers in the United Kingdom appear to experience an episode of depression between their child's birth and 12th year of age, with the highest rates in the first year after birth, according to a report posted online today that will appear in the November print issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
BioSante Pharmaceuticals, Inc., today announced additional positive safety data in its ongoing LibiGel Phase III clinical development program. For the second time, unblinded data have been reviewed by the independent DMC of the LibiGel Cardiovascular and Breast Cancer Safety Study. Based on this review, the DMC once again unanimously recommended continuation of the study as described in the FDA-agreed LibiGel safety study protocol, with no modifications.
A phase 1 clinical trial of sotorasib (AMG 510) in patients with heavily pretreated advanced solid tumors shows encouraging anti-cancer activity, especially in lung and colorectal cancers, reports a new study led by City of Hope and other renowned comprehensive cancer centers.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anthony Louis Greco, MD Po Box 1475, Des Moines, IA 50305-1475 Ph: (515) 643-7900 | Dr Anthony Louis Greco, MD 411 Laurel St Ste A120, Des Moines, IA 50314-3027 Ph: (515) 643-7900 |
News Archive
Today (Wednesday 24 June 2015) His Royal Highness The Prince Charles, Duke of Rothesay will officially open the Golden Jubilee Innovation Centre – a focal point for driving forward innovations for NHSScotland.
Each cell in an organism has a sensor that measures the health of its "internal" environment. This "alarm" is found in the endoplasmic reticulum, which is able to sense cellular stress and trigger either rescue responses or the death of the cell.
More than one-third of mothers and about one-fifth of fathers in the United Kingdom appear to experience an episode of depression between their child's birth and 12th year of age, with the highest rates in the first year after birth, according to a report posted online today that will appear in the November print issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
BioSante Pharmaceuticals, Inc., today announced additional positive safety data in its ongoing LibiGel Phase III clinical development program. For the second time, unblinded data have been reviewed by the independent DMC of the LibiGel Cardiovascular and Breast Cancer Safety Study. Based on this review, the DMC once again unanimously recommended continuation of the study as described in the FDA-agreed LibiGel safety study protocol, with no modifications.
A phase 1 clinical trial of sotorasib (AMG 510) in patients with heavily pretreated advanced solid tumors shows encouraging anti-cancer activity, especially in lung and colorectal cancers, reports a new study led by City of Hope and other renowned comprehensive cancer centers.
› Verified 3 days ago
Dr. Joshua C Lukenbill, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1221 Pleasant Street, Suite 100, Des Moines, IA 50309 Phone: 515-282-2921 Fax: 515-282-1035 | |
Dr. Akshay Mahesh Khatri, M.B.B.S., MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1221 Pleasant St Ste 300, Des Moines, IA 50309 Phone: 515-241-4200 Fax: 515-241-4048 | |
Ravinder Dervesh, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 411 Laurel St Ste 1225, Des Moines, IA 50314 Phone: 515-633-3770 Fax: 515-288-6713 | |
Mr. David Augusto Terrero Salcedo, M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1221 Pleasant St Ste 300, Des Moines, IA 50309 Phone: 515-241-4200 Fax: 515-241-4048 | |
Tyler Mumm, DO Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1111 6th Ave, Des Moines, IA 50314 Phone: 515-643-2261 Fax: 515-643-5802 | |
Bilal Hasan Baig, DO Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1200 Pleasant St, Des Moines, IA 50309 Phone: 515-241-6636 Fax: 515-241-4080 | |
Dr. Sean D Cunningham, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1215 Pleasant St, Ste 206, Des Moines, IA 50309 Phone: 515-875-9092 Fax: 515-875-9828 |